Jean Melville

<i>In vitro</i> and <i>in vivo</i> antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R‐roscovitine)

Steven J. McClue, David Blake, Rosemary G. Clarke et al. · International Journal of Cancer · 2002 · 363 citations · Full text

Seliciclib (CYC202, R-Roscovitine) Induces Cell Death in Multiple Myeloma Cells by Inhibition of RNA Polymerase II–Dependent Transcription and Down-regulation of Mcl-1

David E. MacCallum, Jean Melville, Sheelagh Frame et al. · Cancer Research · 2005 · 284 citations · Full text

Apoptosis, Cell Death, Cell Cycle +16

Structure–activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin

Peter M. Fischer, Nikolai Zhelev, S. Wang et al. · Journal of Peptide Research · 2000 · 167 citations

Structure–activity Relationship, Protein Secretion, Cell Internalization Ability +17

The mechanism of action of the tetrapeptide Acetyl‐N‐Ser‐Asp‐Lys‐Pro (AcSDKP) in the control of haematopoietic stem cell proliferation

Sydney K. Robinson, M. Lenfant, Joanna Wdzieczak‐Bakala et al. · Cell Proliferation · 1992 · 45 citations

Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo.

Anne Rousseau-Plasse, Joanna Wdzieczak‐Bakala, M. Lenfant et al. · PubMed · 1998 · 26 citations